nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ocular cancer—bone cancer	0.169	0.271	CtDrD
Dactinomycin—ABCC6—Cisplatin—bone cancer	0.0991	0.304	CbGbCtD
Dactinomycin—skin cancer—bone cancer	0.0898	0.144	CtDrD
Dactinomycin—muscle cancer—bone cancer	0.0837	0.134	CtDrD
Dactinomycin—germ cell cancer—bone cancer	0.0752	0.121	CtDrD
Dactinomycin—kidney cancer—bone cancer	0.0701	0.112	CtDrD
Dactinomycin—peripheral nervous system neoplasm—bone cancer	0.0694	0.111	CtDrD
Dactinomycin—sarcoma—bone cancer	0.0668	0.107	CtDrD
Dactinomycin—ABCC6—Doxorubicin—bone cancer	0.0664	0.204	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—bone cancer	0.0369	0.113	CbGbCtD
Dactinomycin—ABCG2—Carboplatin—bone cancer	0.0229	0.0703	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—bone cancer	0.0196	0.0602	CbGbCtD
Dactinomycin—ABCG2—Cisplatin—bone cancer	0.0196	0.0601	CbGbCtD
Dactinomycin—ABCC1—Methotrexate—bone cancer	0.019	0.0583	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—bone cancer	0.0131	0.0403	CbGbCtD
Dactinomycin—ABCG2—Methotrexate—bone cancer	0.0127	0.039	CbGbCtD
Dactinomycin—ABCB1—Cisplatin—bone cancer	0.00705	0.0217	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—bone cancer	0.00473	0.0145	CbGbCtD
Dactinomycin—ABCB1—Methotrexate—bone cancer	0.00458	0.0141	CbGbCtD
Dactinomycin—Radiation injury—Epirubicin—bone cancer	0.00205	0.0405	CcSEcCtD
Dactinomycin—Radiation injury—Doxorubicin—bone cancer	0.00189	0.0374	CcSEcCtD
Dactinomycin—Extravasation—Carboplatin—bone cancer	0.00163	0.0323	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Epirubicin—bone cancer	0.00131	0.0259	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Epirubicin—bone cancer	0.00124	0.0245	CcSEcCtD
Dactinomycin—Recall phenomenon—Epirubicin—bone cancer	0.00124	0.0245	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Doxorubicin—bone cancer	0.00121	0.0239	CcSEcCtD
Dactinomycin—Phlebitis—Carboplatin—bone cancer	0.0012	0.0237	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Doxorubicin—bone cancer	0.00115	0.0226	CcSEcCtD
Dactinomycin—Recall phenomenon—Doxorubicin—bone cancer	0.00115	0.0226	CcSEcCtD
Dactinomycin—Myelosuppression—Cisplatin—bone cancer	0.000891	0.0176	CcSEcCtD
Dactinomycin—Proctitis—Epirubicin—bone cancer	0.000879	0.0174	CcSEcCtD
Dactinomycin—Proctitis—Doxorubicin—bone cancer	0.000813	0.0161	CcSEcCtD
Dactinomycin—Febrile neutropenia—Cisplatin—bone cancer	0.000695	0.0137	CcSEcCtD
Dactinomycin—Multi-organ failure—Epirubicin—bone cancer	0.000659	0.013	CcSEcCtD
Dactinomycin—Multi-organ failure—Doxorubicin—bone cancer	0.000609	0.0121	CcSEcCtD
Dactinomycin—Hepatotoxicity—Cisplatin—bone cancer	0.000541	0.0107	CcSEcCtD
Dactinomycin—Necrosis—Cisplatin—bone cancer	0.000533	0.0105	CcSEcCtD
Dactinomycin—Infection—Carboplatin—bone cancer	0.000505	0.00999	CcSEcCtD
Dactinomycin—Raised liver function tests—Methotrexate—bone cancer	0.000497	0.00982	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Methotrexate—bone cancer	0.000497	0.00982	CcSEcCtD
Dactinomycin—Extravasation—Cisplatin—bone cancer	0.000479	0.00947	CcSEcCtD
Dactinomycin—Ascites—Epirubicin—bone cancer	0.000472	0.00934	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Epirubicin—bone cancer	0.000465	0.00919	CcSEcCtD
Dactinomycin—Myelosuppression—Epirubicin—bone cancer	0.000458	0.00905	CcSEcCtD
Dactinomycin—Ulcer—Cisplatin—bone cancer	0.000442	0.00874	CcSEcCtD
Dactinomycin—Ascites—Doxorubicin—bone cancer	0.000437	0.00864	CcSEcCtD
Dactinomycin—Pain—Carboplatin—bone cancer	0.000435	0.0086	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Doxorubicin—bone cancer	0.00043	0.00851	CcSEcCtD
Dactinomycin—Myelosuppression—Doxorubicin—bone cancer	0.000424	0.00838	CcSEcCtD
Dactinomycin—Body temperature increased—Carboplatin—bone cancer	0.000402	0.00795	CcSEcCtD
Dactinomycin—Febrile neutropenia—Methotrexate—bone cancer	0.000381	0.00754	CcSEcCtD
Dactinomycin—Eruption—Methotrexate—bone cancer	0.000373	0.00737	CcSEcCtD
Dactinomycin—Folliculitis—Methotrexate—bone cancer	0.000365	0.00722	CcSEcCtD
Dactinomycin—Febrile neutropenia—Epirubicin—bone cancer	0.000357	0.00706	CcSEcCtD
Dactinomycin—Phlebitis—Cisplatin—bone cancer	0.000352	0.00696	CcSEcCtD
Dactinomycin—Eruption—Epirubicin—bone cancer	0.000349	0.0069	CcSEcCtD
Dactinomycin—Folliculitis—Epirubicin—bone cancer	0.000341	0.00675	CcSEcCtD
Dactinomycin—Febrile neutropenia—Doxorubicin—bone cancer	0.00033	0.00653	CcSEcCtD
Dactinomycin—Eruption—Doxorubicin—bone cancer	0.000323	0.00639	CcSEcCtD
Dactinomycin—Folliculitis—Doxorubicin—bone cancer	0.000316	0.00625	CcSEcCtD
Dactinomycin—Hepatomegaly—Epirubicin—bone cancer	0.000303	0.006	CcSEcCtD
Dactinomycin—Hepatotoxicity—Methotrexate—bone cancer	0.000297	0.00587	CcSEcCtD
Dactinomycin—Necrosis—Methotrexate—bone cancer	0.000292	0.00578	CcSEcCtD
Dactinomycin—Hepatomegaly—Doxorubicin—bone cancer	0.000281	0.00555	CcSEcCtD
Dactinomycin—Necrosis—Epirubicin—bone cancer	0.000273	0.00541	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000273	0.0054	CcSEcCtD
Dactinomycin—Extravasation—Methotrexate—bone cancer	0.000263	0.0052	CcSEcCtD
Dactinomycin—Necrosis—Doxorubicin—bone cancer	0.000253	0.005	CcSEcCtD
Dactinomycin—Pancytopenia—Cisplatin—bone cancer	0.000249	0.00493	CcSEcCtD
Dactinomycin—Extravasation—Epirubicin—bone cancer	0.000246	0.00487	CcSEcCtD
Dactinomycin—Ulcer—Methotrexate—bone cancer	0.000242	0.0048	CcSEcCtD
Dactinomycin—Hypocalcaemia—Epirubicin—bone cancer	0.000234	0.00464	CcSEcCtD
Dactinomycin—Stomatitis—Cisplatin—bone cancer	0.000228	0.00451	CcSEcCtD
Dactinomycin—Extravasation—Doxorubicin—bone cancer	0.000228	0.0045	CcSEcCtD
Dactinomycin—Ulcer—Epirubicin—bone cancer	0.000227	0.00449	CcSEcCtD
Dactinomycin—Hypocalcaemia—Doxorubicin—bone cancer	0.000217	0.00429	CcSEcCtD
Dactinomycin—Aplastic anaemia—Methotrexate—bone cancer	0.000215	0.00426	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—bone cancer	0.00021	0.00415	CcSEcCtD
Dactinomycin—Mouth ulceration—Methotrexate—bone cancer	0.000207	0.0041	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—bone cancer	0.000202	0.00399	CcSEcCtD
Dactinomycin—Sepsis—Methotrexate—bone cancer	0.000199	0.00394	CcSEcCtD
Dactinomycin—Oesophagitis—Epirubicin—bone cancer	0.000196	0.00388	CcSEcCtD
Dactinomycin—Flushing—Cisplatin—bone cancer	0.000195	0.00385	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—bone cancer	0.000194	0.00384	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—bone cancer	0.000186	0.00369	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—bone cancer	0.000186	0.00368	CcSEcCtD
Dactinomycin—Alopecia—Cisplatin—bone cancer	0.000185	0.00367	CcSEcCtD
Dactinomycin—Hepatic failure—Methotrexate—bone cancer	0.000185	0.00366	CcSEcCtD
Dactinomycin—Erythema—Cisplatin—bone cancer	0.000183	0.00361	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—bone cancer	0.000181	0.00359	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—bone cancer	0.000181	0.00358	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—bone cancer	0.00018	0.00355	CcSEcCtD
Dactinomycin—Hepatic failure—Epirubicin—bone cancer	0.000173	0.00343	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—bone cancer	0.000172	0.00341	CcSEcCtD
Dactinomycin—Lethargy—Methotrexate—bone cancer	0.00017	0.00336	CcSEcCtD
Dactinomycin—Ill-defined disorder—Cisplatin—bone cancer	0.00017	0.00335	CcSEcCtD
Dactinomycin—Anaemia—Cisplatin—bone cancer	0.000169	0.00334	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—bone cancer	0.000167	0.00331	CcSEcCtD
Dactinomycin—Malaise—Cisplatin—bone cancer	0.000165	0.00326	CcSEcCtD
Dactinomycin—Leukopenia—Cisplatin—bone cancer	0.000164	0.00323	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—bone cancer	0.00016	0.00317	CcSEcCtD
Dactinomycin—Lethargy—Epirubicin—bone cancer	0.000159	0.00314	CcSEcCtD
Dactinomycin—Myalgia—Cisplatin—bone cancer	0.000156	0.00308	CcSEcCtD
Dactinomycin—Liver function test abnormal—Methotrexate—bone cancer	0.000154	0.00304	CcSEcCtD
Dactinomycin—Discomfort—Cisplatin—bone cancer	0.000154	0.00304	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00015	0.00297	CcSEcCtD
Dactinomycin—Oedema—Cisplatin—bone cancer	0.000149	0.00295	CcSEcCtD
Dactinomycin—Infection—Cisplatin—bone cancer	0.000148	0.00293	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—bone cancer	0.000147	0.00291	CcSEcCtD
Dactinomycin—Thrombocytopenia—Cisplatin—bone cancer	0.000146	0.00289	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—bone cancer	0.000144	0.00284	CcSEcCtD
Dactinomycin—Anorexia—Cisplatin—bone cancer	0.000142	0.00281	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00014	0.00277	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00014	0.00277	CcSEcCtD
Dactinomycin—Pancytopenia—Methotrexate—bone cancer	0.000137	0.0027	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000136	0.00269	CcSEcCtD
Dactinomycin—Dysphagia—Epirubicin—bone cancer	0.000135	0.00266	CcSEcCtD
Dactinomycin—Neutropenia—Methotrexate—bone cancer	0.000135	0.00266	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—bone cancer	0.000133	0.00263	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00013	0.00257	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00013	0.00257	CcSEcCtD
Dactinomycin—Decreased appetite—Cisplatin—bone cancer	0.00013	0.00256	CcSEcCtD
Dactinomycin—Pneumonia—Methotrexate—bone cancer	0.000129	0.00255	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—bone cancer	0.000128	0.00253	CcSEcCtD
Dactinomycin—Pain—Cisplatin—bone cancer	0.000128	0.00252	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000127	0.00252	CcSEcCtD
Dactinomycin—Neutropenia—Epirubicin—bone cancer	0.000126	0.00249	CcSEcCtD
Dactinomycin—Stomatitis—Methotrexate—bone cancer	0.000125	0.00247	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—bone cancer	0.000125	0.00246	CcSEcCtD
Dactinomycin—Feeling abnormal—Cisplatin—bone cancer	0.000123	0.00243	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—bone cancer	0.000121	0.00239	CcSEcCtD
Dactinomycin—Agranulocytosis—Methotrexate—bone cancer	0.00012	0.00237	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000119	0.00235	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—bone cancer	0.000118	0.00234	CcSEcCtD
Dactinomycin—Body temperature increased—Cisplatin—bone cancer	0.000118	0.00233	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—bone cancer	0.000117	0.00231	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—bone cancer	0.000117	0.0023	CcSEcCtD
Dactinomycin—Hepatitis—Methotrexate—bone cancer	0.000115	0.00228	CcSEcCtD
Dactinomycin—Pharyngitis—Methotrexate—bone cancer	0.000114	0.00226	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—bone cancer	0.000112	0.00222	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—bone cancer	0.000112	0.00221	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00011	0.00218	CcSEcCtD
Dactinomycin—Hypersensitivity—Cisplatin—bone cancer	0.00011	0.00217	CcSEcCtD
Dactinomycin—Erythema multiforme—Methotrexate—bone cancer	0.000109	0.00215	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—bone cancer	0.000108	0.00214	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—bone cancer	0.000108	0.00213	CcSEcCtD
Dactinomycin—Asthenia—Cisplatin—bone cancer	0.000107	0.00212	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—bone cancer	0.000107	0.00212	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—bone cancer	0.000104	0.00205	CcSEcCtD
Dactinomycin—Chills—Methotrexate—bone cancer	0.000103	0.00204	CcSEcCtD
Dactinomycin—Diarrhoea—Cisplatin—bone cancer	0.000102	0.00202	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—bone cancer	0.000102	0.00202	CcSEcCtD
Dactinomycin—Alopecia—Methotrexate—bone cancer	0.000102	0.00201	CcSEcCtD
Dactinomycin—Erythema—Methotrexate—bone cancer	0.0001	0.00198	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—bone cancer	0.0001	0.00198	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—bone cancer	9.97e-05	0.00197	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—bone cancer	9.9e-05	0.00196	CcSEcCtD
Dactinomycin—Chills—Epirubicin—bone cancer	9.67e-05	0.00191	CcSEcCtD
Dactinomycin—Alopecia—Epirubicin—bone cancer	9.53e-05	0.00188	CcSEcCtD
Dactinomycin—Vomiting—Cisplatin—bone cancer	9.48e-05	0.00188	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—bone cancer	9.43e-05	0.00186	CcSEcCtD
Dactinomycin—Rash—Cisplatin—bone cancer	9.4e-05	0.00186	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—bone cancer	9.38e-05	0.00186	CcSEcCtD
Dactinomycin—Ill-defined disorder—Methotrexate—bone cancer	9.3e-05	0.00184	CcSEcCtD
Dactinomycin—Anaemia—Methotrexate—bone cancer	9.27e-05	0.00183	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—bone cancer	9.26e-05	0.00183	CcSEcCtD
Dactinomycin—Malaise—Methotrexate—bone cancer	9.04e-05	0.00179	CcSEcCtD
Dactinomycin—Leukopenia—Methotrexate—bone cancer	8.98e-05	0.00177	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—bone cancer	8.95e-05	0.00177	CcSEcCtD
Dactinomycin—Nausea—Cisplatin—bone cancer	8.86e-05	0.00175	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—bone cancer	8.81e-05	0.00174	CcSEcCtD
Dactinomycin—Ill-defined disorder—Epirubicin—bone cancer	8.71e-05	0.00172	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—bone cancer	8.68e-05	0.00172	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—bone cancer	8.67e-05	0.00172	CcSEcCtD
Dactinomycin—Myalgia—Methotrexate—bone cancer	8.54e-05	0.00169	CcSEcCtD
Dactinomycin—Malaise—Epirubicin—bone cancer	8.46e-05	0.00167	CcSEcCtD
Dactinomycin—Discomfort—Methotrexate—bone cancer	8.43e-05	0.00167	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—bone cancer	8.4e-05	0.00166	CcSEcCtD
Dactinomycin—Infection—Methotrexate—bone cancer	8.13e-05	0.00161	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—bone cancer	8.06e-05	0.00159	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—bone cancer	8.02e-05	0.00159	CcSEcCtD
Dactinomycin—Thrombocytopenia—Methotrexate—bone cancer	8.01e-05	0.00158	CcSEcCtD
Dactinomycin—Myalgia—Epirubicin—bone cancer	7.99e-05	0.00158	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—bone cancer	7.89e-05	0.00156	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—bone cancer	7.83e-05	0.00155	CcSEcCtD
Dactinomycin—Anorexia—Methotrexate—bone cancer	7.8e-05	0.00154	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—bone cancer	7.77e-05	0.00154	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—bone cancer	7.66e-05	0.00151	CcSEcCtD
Dactinomycin—Infection—Epirubicin—bone cancer	7.61e-05	0.0015	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—bone cancer	7.5e-05	0.00148	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methotrexate—bone cancer	7.46e-05	0.00147	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—bone cancer	7.39e-05	0.00146	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—bone cancer	7.3e-05	0.00144	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—bone cancer	7.3e-05	0.00144	CcSEcCtD
Dactinomycin—Decreased appetite—Methotrexate—bone cancer	7.11e-05	0.00141	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—bone cancer	7.09e-05	0.0014	CcSEcCtD
Dactinomycin—Fatigue—Methotrexate—bone cancer	7.06e-05	0.0014	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—bone cancer	7.04e-05	0.00139	CcSEcCtD
Dactinomycin—Pain—Methotrexate—bone cancer	7e-05	0.00138	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—bone cancer	6.98e-05	0.00138	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—bone cancer	6.94e-05	0.00137	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—bone cancer	6.75e-05	0.00134	CcSEcCtD
Dactinomycin—Feeling abnormal—Methotrexate—bone cancer	6.74e-05	0.00133	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methotrexate—bone cancer	6.69e-05	0.00132	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—bone cancer	6.66e-05	0.00132	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—bone cancer	6.6e-05	0.00131	CcSEcCtD
Dactinomycin—Pain—Epirubicin—bone cancer	6.55e-05	0.0013	CcSEcCtD
Dactinomycin—Body temperature increased—Methotrexate—bone cancer	6.47e-05	0.00128	CcSEcCtD
Dactinomycin—Abdominal pain—Methotrexate—bone cancer	6.47e-05	0.00128	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—bone cancer	6.46e-05	0.00128	CcSEcCtD
Dactinomycin—Feeling abnormal—Epirubicin—bone cancer	6.31e-05	0.00125	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—bone cancer	6.26e-05	0.00124	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—bone cancer	6.16e-05	0.00122	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—bone cancer	6.11e-05	0.00121	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—bone cancer	6.06e-05	0.0012	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—bone cancer	6.05e-05	0.0012	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—bone cancer	6.05e-05	0.0012	CcSEcCtD
Dactinomycin—Hypersensitivity—Methotrexate—bone cancer	6.03e-05	0.00119	CcSEcCtD
Dactinomycin—Asthenia—Methotrexate—bone cancer	5.87e-05	0.00116	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—bone cancer	5.84e-05	0.00115	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—bone cancer	5.79e-05	0.00115	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—bone cancer	5.64e-05	0.00112	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—bone cancer	5.6e-05	0.00111	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—bone cancer	5.6e-05	0.00111	CcSEcCtD
Dactinomycin—Diarrhoea—Methotrexate—bone cancer	5.6e-05	0.00111	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—bone cancer	5.49e-05	0.00109	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—bone cancer	5.24e-05	0.00104	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—bone cancer	5.22e-05	0.00103	CcSEcCtD
Dactinomycin—Vomiting—Methotrexate—bone cancer	5.2e-05	0.00103	CcSEcCtD
Dactinomycin—Rash—Methotrexate—bone cancer	5.16e-05	0.00102	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—bone cancer	5.08e-05	0.00101	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—bone cancer	4.87e-05	0.000963	CcSEcCtD
Dactinomycin—Nausea—Methotrexate—bone cancer	4.86e-05	0.000961	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—bone cancer	4.85e-05	0.000959	CcSEcCtD
Dactinomycin—Rash—Epirubicin—bone cancer	4.83e-05	0.000955	CcSEcCtD
Dactinomycin—Nausea—Epirubicin—bone cancer	4.55e-05	0.0009	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—bone cancer	4.51e-05	0.000891	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—bone cancer	4.47e-05	0.000884	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—bone cancer	4.21e-05	0.000832	CcSEcCtD
